Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference

Journal of the American Medical Directors Association

Volumn 16, Issue 9, 2015, Pages 731-739

  Morley, John E ^a   Morris, John C ^b   Berg Weger, Marla ^a   Borson, Soo ^c   Carpenter, Brian D ^b   del Campo, Natalia ^d   Dubois, Bruno ^e   Fargo, Keith ^f   Fitten, L Jaime ^g   Flaherty, Joseph H ^a   Ganguli, Mary ^h   Grossberg, George T ^a   Malmstrom, Theodore K ^a   Petersen, Ronald D ⁱ   Rodriguez, Carroll ^f   Saykin, Andrew J ^j   Scheltens, Philip ^k   Tangalos, Eric G ^l   Verghese, Joe ^m   Wilcock, Gordon ⁿ   Winblad, Bengt ^o   Woo, Jean ^p   Vellas, Bruno ^d   more..

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f ALZHEIMER'S ASSOCIATION   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ Mayo Clinic   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^l MAYO CLINIC   (United States)

^m ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o KAROLINSKA INSTITUTE   (Sweden)

^p CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Alzheimer disease; Case finding; Cognitive frailty; Cognitive impairment; MCI

Indexed keywords

BIOLOGICAL MARKER;

AGING; ARTICLE; COGNITION; COGNITIVE DEFECT; COGNITIVE FRAILTY; DECISION MAKING; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FAMILY; FINANCIAL MANAGEMENT; FRIEND; GOVERNMENT; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; MENTAL DISEASE ASSESSMENT; MENTAL HEALTH CARE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PATIENT RIGHT; PHYSICIAN; PSYCHOSOCIAL CARE; REIMBURSEMENT; SCREENING TEST; SELF REPORT; UNITED STATES; WEAKNESS; AGED; COGNITION DISORDERS; CONSENSUS DEVELOPMENT; MASS SCREENING;

AGED; COGNITION DISORDERS; DECISION MAKING; EARLY DIAGNOSIS; HUMANS; MASS SCREENING;

EID: 84940048509     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.06.017     Document Type: Article

References (159)

1. Petersen R.C. Clinical practice. Mild cognitive impairment. N Engl J Med 2011, 364:2227-2234.
2. Morley J.E. Mild cognitive impairment-a treatable condition. J Am Med Dir Assoc 2014, 15:1-5.
3. Winblad B., Palmer K., Kivipelto M., et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 256:240-246.
4. Ferri C.P., Prince M., Brayne C., et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005, 366:2112-2117.
5. Hugo J., Ganguli M. Dementia and cognitive impairment: Epidemiology, diagnosis, and treatment. Clin Geriatr Med 2014, 30:421-442.
6. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of demented old people. J Neurol Sci 1970, 11:205-242.
7. Chui H.C., Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther 2015, 7:21.
8. Zhang Y., Xu Y., Nie H., et al. Prevalence of dementia and major dementia subtypes in the Chinese populations: A meta-analysis of dementia prevalence surveys, 1980-2010. J Clin Neurosci 2012, 19:1333-1337.
9. de Pedro-Cuesta J., Virues-Ortega J., Vega S., et al. Prevalence of dementia and major dementia subtypes in Spanish populations: A re-analysis of dementia prevalence surveys, 1990-2008. BMC Neurol 2009, 9:55.
10. Kelaiditi E., Cesari M., Canevelli M., et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging 2013, 17:726-734.
11. Malmstrom T.K., Morley J.E. Frailty and cognition: Linking two common syndromes in older persons. J Nutr Health Aging 2013, 17:723-725.
12. Fitten I.J. Thinking about cognitive frailty. J Prev Alzheimers Dis 2015, 2:7-10.
13. Morley J.E., Abbatecola A.M., Argiles J.M., et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011, 12:403-409.
14. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013, 14:392-397.
15. Morris J.C., Blennow K., Froelich L., et al. Harmonized diagnostic criteria for Alzheimer's disease: Recommendations. J Intern Med 2014, 275:204-213.
16. Cordell C.B., Borson S., Boustani M., et al. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness visit in a primary care setting. Alzheimers Dement 2013, 9:141-150.
17. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
18. Tangalos E.G., Smith G.E., Ivnik R.J., et al. The Mini-Mental State Examination in general medical practice: Clinical utility and acceptance. Mayo Clin Proc 1996, 71:829-837.
19. Subra J., Gillette-Guyonnet S., Cesari M., et al. The integration of frailty into clinical practice: Preliminary results from the Gerontopole. J Nutr Health Aging 2012, 16:714-720.
20. McCarten J.R., Anderson P., Kuskowski M.A., et al. Screening for cognitive impairment in an elderly veteran population: Acceptability and results using different versions of the Mini-Cog. J Am Geriatr Soc 2011, 59:309-313.
21. Bayley P.J., Kong J.Y., Mendiondo M., et al. Findings from the national memory screening day program. J Am Geriatr Soc 2015, 63:309-314.
22. Cruz-Oliver D.M., Malmstrom T.K., Allen C.M., et al. The Veterans Affairs St. Louis University mental status exam (SLUMS exam) and the Mini-mental status exam as predictors of mortality and institutionalization. J Nutr Health Aging 2012, 16:636-641.
23. Woo J., Yu R., Wong M., et al. Frailty screening in the community using the FRAIL scale. J Am Med Dir Assoc 2015, 16:412-419.
24. Ross G.W., Abbott R.D., Petrovitch H., et al. Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA 1997, 277:800-805.
25. Jansen A.P., van Hout H.P., Nijpels G., et al. Yield of new method to detect cognitive impairment in general practice. Int J Geriatr Psychiatry 2007, 22:590-597.
26. Miller D.K., Morley J.E., Rubenstein L.Z., et al. Formal geriatric assessment instruments and the care of older general medical outpatients. J Am Geriatr Soc 1990, 38:645-651.
27. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Available at: . Accessed March 29, 2015. http://www.alz.org/facts/overview.asp.
28. Tierney M.C., Naglie G., Upshur R., et al. Factors associated with primary care physicians' recognition of cognitive impairment in their older patients. Alzheimer Dis Assoc Disord 2014, 28:320-325.
29. Lin JS, O'Connor E, Rossom RC, et al. Screening for cognitive impairment in older adults: An evidence update for the U.S. Preventive services task force. Agency for healthcare research and quality (US). 2013 (Nov) report No:14-05198-EF-1. Available at: . Accessed March 25, 2015. http://www.ncbi.nlm.nih.gov/pubmed/24354019.
30. Imtiaz B., Tolppanen A.M., Kivipelto M., Soininen H. Future directions in Alzheimer's disease from risk factors to prevention. Biochem Pharmacol 2014, 88:661-670.
31. Chin R., Ng A., Narasimhalu K., Kandiah N. Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population. Am J Alzheimers Dis Other Demen 2013, 28:284-288.
32. Malmstrom T.K., Miller D.K., Coats M.A., et al. Informant-based dementia screening in a population-based sample of African Americans. Alzheimer Dis Assoc Disord 2009, 23:117-123.
33. Galvin J.E., Roe C.M., Powlishta K.K., et al. The AD8: A brief informant interview to detect dementia. Neurology 2005, 65:559-564.
34. Galvin J.E., Roe C.M., Xiong C., Morris J.C. Validity and reliability of the AD8 informant interview in dementia. Neurology 2006, 67:1942-1948.
35. Rueda A.D., Lau K.M., Saito N., et al. Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease. Alzheimers Dement 2014, Alzheimer's Disease Neuroimaging Initiative, [published online ahead of print November 15, 2014]. 10.1016/j.jalz.2014.09.002.
36. Meguro K., Kasai M., Nakamura K. Kurihara Project members. Reliability and validity of the Japanese version of the AD8. Nihon Ronen Igakkai Zaashi 2015, 52:61-70.
37. Xie Y., Gao Y., Jia J., et al. Utility of AD8 for cognitive impairment in a Chinese physical examination population: A preliminary study. ScientificWorldJournal 2014, 2014:804871.
38. Chen C.H., Wang L.C., Ma T.C., Yang Y.H. A walk-in screening of dementia in the general population in Taiwan. ScientificWorldJournal 2014, 2014:243738.
39. Li T., Wang H.L., Yang Y.H., et al. The reliability and validity of Chinese version of AD8. Zhonghua Nie Ke Za Zhi 2012, 51:777-780. [Chinese].
40. Carnero Pardo C., de la Vega Cotarelo R., López Alcalde S., et al. Assessing the diagnostic accuracy (DA) of the Spanish version of the informant-based AD8 questionnaire. Neurologia 2013, 28:88-94.
41. Correia C.C., Lima F., Junqueira F., et al. AD8-Brazil: Cross-cultural validation of the ascertaining dementia interview in Portuguese. J Alzheimers Dis 2011, 27:177-185.
42. Borson S., Scanlan J., Brush M., et al. The mini-cog: A cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000, 15:1021-1027.
43. Scanlan J., Borson S. The Mini-Cog: Receiver operating characteristics with expert and naïve raters. Int J Geriatr Psychiatry 2001, 16:216-222.
44. Borson S., Scanlan J.M., Chen P., Ganguli M. The Mini-Cog as a screen for dementia: Validation in a population-based sample. J Am Geriatr Soc 2003, 51:1451-1454.
45. Setter S.M., Neumiller J.J., Johnson M., et al. The mini-cog: A rapid dementia screening tool suitable for pharmacists' use. Consult Pharm 2007, 22:855-861.
46. Malmstrom T.K., Voss V.B., Cruz-Oliver D.M., et al. Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 2015, 19:741-744.
47. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 2006, 14:900-910.
48. Feliciano L., Horning S.M., Klebe K.J., et al. Utility of the SLUMS as a cognitive screening tool among a nonveteran sample of older adults. Am J Geriatr Psychiatry 2013, 21:623-630.
49. Cummings-Vaughn L.A., Chavakula N.N., Malmstrom T.K., et al. Veterans Affairs Saint Louis University mental status examination compared with the Montreal cognitive assessment and the short test of mental status. J Am Geriatr Soc 2014, 62:1341-1346.
50. Dubois B., Touchon J., Portet F., et al. "The 5 words": A simple and sensitive test for the diagnosis of Alzheimer's disease. Presse Med 2002, 31:1696-1699. [French].
51. Wicklund M., Petersen R.C. Emerging biomarkers in cognition. Clin Geriatr Med 2013, 29:809-828.
52. Morris J.C., Kimberly A., Quaid K., et al. Role of biomarkers in studies of presymptomatic Alzheimer's disease. Alzheimers Dement 2005, 1:145-151.
53. Ariza M., Kolb H.C., Moechars D., et al. Tau positron emissions tomography (PET) imaging: Past, present, and future. J Med Chem 2015, 58:4365-4382.
54. McCleery J., Morgan S., Bradley K.M., et al. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database Syst Rev 2015, (1):CD010633.
55. Bocchetta M., Galluzzi S., Kehoe P.G., et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimers Dement 2015, 11:195-206.e1.
56. McKhann G.M., Knopman D.S., Chertkow H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
57. Prestia A., Caroli A., Wade S.K., et al. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimers Dement 2015, [published online ahead of print January 31, 2015]. 10.1016/j.jalz.2014.12.001.
58. Cummings J.L., Dubois B., Molinuevo J.L., Scheltens P. International Work Group criteria for the diagnosis of Alzheimer disease. Med Clin North Am 2013, 97:363-368.
59. Zaleta A.K., Carpenter B.D., Porensky E.K., et al. Agreement on diagnosis among patients, companions, and professionals after a dementia evaluation. Alzheimer Dis Assoc Disord 2012, 26:232-237.
60. Morley J.E. Anticholinergic medications and cognition. J Am Med Dir Assoc 2011, 12:543-543.e1.
61. Campbell N., Boustani M., Limbil T., et al. The cognitive impact of anticholinergics: A clinical review. Clin Inter Aging 2009, 4:225-233.
62. Cruz-Oliver D.M., Malmstrom T.K., Roegner M., et al. Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years later. J Am Med Dir Assoc 2014, 15:687.e5-687.e10.
63. Morandi A., Bellelli G., Vasilevskis E.E., et al. Predictors of rehospitalization among elderly patients admitted to a rehabilitation hospital: The role of polypharmacy, functional status, and length of stay. J Am Med Dir Assoc 2013, 14:761-767.
64. Tsai R., Noone M., Johnson B., et al. Potentially inappropriate medication use in individuals with mild cognitive impairment: Results from the Kerala Einstein Study. J Am Geriatr Soc 2012, 60:1369-1370.
65. Thakur M., Blazer D.G. Depression in long-term care. J Am Med Dir Assoc 2008, 9:82-87.
66. Osterweil D., Syndulko K., Cohen S.N., et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992, 40:325-335.
67. Suchorska B., Kunz M., Schniepp R., et al. Optimized surgical treatment for normal pressure hydrocephalus: Comparison between gravitational and differential pressure valves. Acta Neurochir (Wien) 2015, 157:703-709.
68. Olaithe M., Bucks R.S. Executive dysfunction in OSA before and after treatment: A meta-analysis. Sleep 2013, 36:1297-1305.
69. Lal C., Strange C., Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest 2012, 141:1601-1610.
70. Van der Flier W.M., van Straaten E.C., Barkhof F., et al. Small vessel disease and general cognitive function in nondisabled elderly: The LADIS study. Stroke 2005, 36:2116-2120.
71. Kloppenborg R.P., Nederkoorn P.J., Geerlings M.I., van den Berg E. Presence and progression of white matter hyperintensities and cognition: A meta-analysis. Neurology 2014, 82:2127-2138.
72. Overdorp E.J., Kessels R.P., Claassen J.A., Oosterman J.M. Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: An MRI study in memory clinic patients. Front Aging Neurosci 2014, 6:98.
73. Wakefield D.B., Moscufo N., Guttmann C.R., et al. White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults. J Am Geriatr Soc 2010, 58:275-281.
74. Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010, 9:689-701.
75. Pantoni L., Poggesi A., Inzitari D. Cognitive decline and dementia related to cerebrovascular diseases: Some evidence and concepts. Cerebrovasc Dis 2009, 27:191-196.
76. Ganguli M., Fu B., Snitz B.E., et al. Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort. Neurology 2013, 80:2112-2120.
77. Singh B., Mielke M.M., Parsaik A.K., et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol 2014, 71:581-588.
78. Ampadu J., Morley J.E. Heart failure and cognitive dysfunction. Int J Cardiol 2015, 178:12-23.
79. Cheng G., Huang C., Deng H., Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 2012, 42:484-491.
80. Geijselaers S.L., Sep S.J., Stehouwer C.D., Biessels G.J. Glucose regulation, and brain MRI in type 2 diabetes: A systematic review. Lancet Diabetes Endocrinol 2015, 3:75-89.
81. Biessels G.J., Reijmer Y.D. Brain changes underlying cognitive dysfunction in diabetes: What can we learn from MRI?. Diabetes 2014, 63:2244-2252.
82. McNeilly G.S., Cheung E., Tessier D., et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993, 48:M117-M121.
83. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990, 13:16-21.
84. Flood J.F., Mooradian A.D., Morley J.E. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 1990, 39:1391-1398.
85. Psaltopoulou T., Sergentanis T.N., Panagiotakos D.B., et al. Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol 2013, 74:580-591.
86. Singh B., Parsaik A.K., Mielke M.M., et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis 2014, 39:271-282.
87. Solfrizzi V., Panza F. Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: What challenges lie ahead?. J Alzheimers Dis 2014, 39:283-286.
88. Martinez-Lapiscina E.H., Clavero P., Toledo E., et al. Mediterranean diet improves cognition: The PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 2013, 84:1318-1325.
89. Martinez-Lapiscina E.H., Clavero P., Toledo E., et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized trial. J Nutr Health Aging 2013, 17:544-552.
90. Farr S.A., Price T.O., Dominguez L.J., et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012, 28:81-92.
91. Tangney C.C., Li H., Wang Y., et al. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology 2014, 83:1410-1416.
92. Morris M.C., Tangney C.C., Wang Y., et al. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement 2015, [published online ahead of print February 11, 2015]. 10.1016/j.jalz.2014.11.009.
93. Barnard N.D., Bush A.I., Ceccarelli A., et al. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging 2014, 35:S74-S78.
94. Shah R. The role of nutrition and diet in alzheimer disease: A systematic review. J Am Med Dir Assoc 2013, 14:398-402.
95. Farina N., Isaac M.G., Clark A.R., et al. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev 2012, (11):CD002854.
96. Dysken M.W., Sano M., Asthana S., et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: The TEAM-AD VA cooperative randomized trial. JAMA 2014, 311:33-44.
97. Li M.M., Yu J.T., Wang H.F., et al. Efficacy of vitamin B supplementation on mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis. Curr Alzheimer Res 2014, 11:844-852.
98. Dangour A.D., Whitehouse P.J., Rafferty K., et al. B-Vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: A systematic review. J Alzheimers Dis 2010, 22:205-224.
99. Malouf R., Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003, (3):CD004326.
100. Cheng D., Kong H., Pang W., et al. B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinemia. Nutr Neurosci 2014, [published online ahead of print June 18, 2014].
101. van Wijk N., Broersen L.M., de Wilde M.C., et al. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis 2014, 38:459-479.
102. Olde Rikkert M.G., Verhey F.R., Sijben J.W., et al. Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls. J Alzheimers Dis 2014, 41:261-271.
103. Shah R.C., Kamphuis P.J., Leurgans S., et al. The S-Connect study: Results from a randomized, controlled trial of souvenaid in mild-to-moderate Alzheimer's disease. Alzheimers Res Ther 2013, 5:59.
104. Olde Rikkert M.G., Verhey F.R., Blesa R., et al. Tolerability and safety of souvenaid in patients with mild Alzheimer's disease: Results of multi-center, 24-week, open-label extension study. J Alzheimers Dis 2015, 44:471-480.
105. Sharma A., Bemis M., Desilets A.R. Role of medium chain triglycerides (Axona(R)) in the treatment of mild to moderate Alzheimer's disease. Am J Alzheimers Dis Other Demen 2014, [published online ahead of print January 9, 2014].
106. Henderson S.T., Vogel J.L., Barr L.J., et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009, 6:31.
107. Norton S., Matthews F.E., Barnes D.E., et al. Potential for primary prevention of Alzheimer's disease: An analysis of population-based data. Lancet Neurol 2014, 13:788-794.
108. Sofi F., Valecchi D., Bacci D., et al. Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J Intern Med 2011, 269:107-117.
109. Angevaren M., Aufdemkampe G., Verhaar H.J., et al. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008, (3):CD005381.
110. Gates N., Fiatarone Singh M.A., Sachdev P.S., Valenzuela M. The effect of exercise training on cognitive function in older adults with mild cognitive impairment: A meta-analysis of randomized controlled trials. Am J Geriatr Psychiatry 2013, 21:1086-1097.
111. Wang C., Yu J.T., Wang H.F., et al. Non-pharmacological interventions for patients with mild cognitive impairment: A meta-analysis of randomized controlled trials of cognition-based and exercise interventions. J Alzheimers Dis 2014, 42:663-678.
112. Erickson K.I., Voss M.W., Prakash R.S., et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 2011, 108:3017-3022.
113. Voss M.W., Heo S., Prakash R.S., et al. The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: Results of a one-year exercise intervention. Hum Brain Mapp 2013, 34:2972-2985.
114. Fiatarone Singh M.A., Gates N., Saigal N., et al. The study of mental and resistance training (SMART) study-resistance training and/or cognitive training in mild cognitive impairment: A randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc 2014, 15:873-880.
115. Lautenschlager N.T., Cox K.L., Flicker L., et al. Effect of physical activity on cognitive function in older adults at risk for alzheimer disease: A randomized trial. JAMA 2008, 300:1027-1037.
116. Wayne P.M., Walsh J.N., Taylor-Piliae R.E., et al. Effect of tai chi on cognitive performance in older adults: Systematic review and meta-analysis. J Am Geriatr Soc 2014, 62:25-39.
117. Lam L.C., Chau R.C., Wong B.M., et al. A 1-year randomized controlled trial comparing mind body exercise (Tai Chi) while stretching and toning exercise on cognitive function in older Chinese adults at risk of cognitive decline. J Am Med Dir Assoc 2012, 13:568.e15-568.e20.
118. Beydoun M.A., Beydoun H.A., Gamaldo A.A., et al. Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis. BMC Public Health 2014, 14:643.
119. Verghese J., Lipiton R.B., Katz M.J., et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003, 348:2508-2516.
120. Verghese J., Wang Cuiling, Katz M.J., et al. Leisure activities and risk of vascular cognitive impairment in older adults. J Geriatr Psychiatry Neurol 2009, 22:110-118.
121. Hall C.B., Lipton R.B., Sliwinski M., et al. Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology 2009, 73:356-361.
122. Unverzagt F.W., Guey L.T., Jones R.N., et al. ACTIVE cognitive training and rates of incident dementia. J Int Neuropsychol Soc 2012, 18:669-677.
123. Jones R.N., Marsiske M., Ball K., et al. The ACTIVE cognitive training interventions and trajectories of performance among older adults. J Aging Health 2013, 25:186S-208S.
124. Woods B., Aguirre E., Spector A.E., Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012, (2):CD005562.
125. Simon S.S., Yokomizo J.E., Bottino C.M.C. Cognitive intervention in amnestic mild cognitive impairment: A systematic review. Neurosci Biobehav Rev 2012, 36:1163-1178.
126. D'Amico F., Rehill A., Knapp M., et al. Maintenance cognitive stimulation therapy: An economic evaluation within a randomized controlled trial. J Am Med Dir Assoc 2015, 16:63-70.
127. Loraine J., Taylor S., McAllister M. Cognitive and physical stimulation therapy. J Am Med Dir Assoc 2014, 15:140-141.
128. Kawashima R., Hiller D.L., Sereda S.L., et al. SAIDO learning as a cognitive intervention for dementia care: A preliminary study. J Am Med Dir Assoc 2015, 16:56-62.
129. Karlin B.E., Visnic S., McGee J.S., Teri L. Results from the multisite implementation of STAR-VA: A multicomponent psychosocial intervention for managing challenging dementia-related behaviors of veterans. Psychol Serv 2014, 11:200-208.
130. Teri L., Huda P., Gibbons L., et al. STAR: A dementia-specific training program for staff in assisted living residencies. Gerontologist 2005, 45:686-693.
131. Woods B., Thorgrimsen L., Spector A., et al. Improved quality of life and cognitive stimulation therapy in dementia. Aging Ment Health 2006, 10:219-226.
132. Law L.L.F., Barnett F., Yau M.K., Gray M.A. Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: A systematic review. Ageing Res Rev 2014, 15:61-75.
133. Wingbermuehle C., Bryer D., Berg-Weger M., et al. Baseball reminiscence league: A model for supporting persons with dementia. J Am Med Dir Assoc 2014, 15:85-89.
134. van Bogaert P., Van Grinsven R., Tolson D., et al. Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to alzheimer disease: A pilot study. J Am Med Dir Assoc 2013, 14:528.e9-528.e13.
135. Woods B., Spector A., Jones C., et al. Reminiscence therapy for dementia. Cochrane Database Syst Rev 2005, (2):CD001120.
136. Toril P., Reales J.M., Ballesteros S. Video game training enhances cognition of older adults: A meta-analytic study. Psychol Aging 2014, 29:706-716.
137. Kueider A.M., Parisi J.M., Gross A.L., Rebok G.W. Computerized cognitive training with older adults: A systematic review. PLoS One 2012, 7:e40588.
138. Daviglus M.L., Bell C.C., Berrettini W., et al. National Institutes of Health State-of-the-Science Conference statement: Preventing Alzheimer disease and cognitive decline. Ann Intern Med 2010, 153:176-181.
139. Solomon A., Mangialasche F., Richard E., et al. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med 2014, 275:229-250.
140. Ngandu T., Lehtisalo J., Solomon A., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomized controlled trial. Lancet 2015, 385:2255-2263.
141. Kivipelto M., Ngandu T., Laatikainen T., et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. Lancet Neurol 2006, 5:735-741.
142. Knopman D.S., Petersen R.C. Mild cognitive impairment and mild dementia: A clinical perspective. Mayo Clin Proc 2014, 89:1452-1459.
143. Dean K., Wilcock G. Living with mild cognitive impairment: The patient's and carer's experience. Int Psychogeriatr 2012, 24:871-881.
144. Panza F., Solfrizzi V., Barulli M.R., et al. Cognitive frailty-epidemiological and neurobiological evidence of an age-related clinical condition: A systematic review. Rejuvenation Res 2015, [published online ahead of print March 26, 2015].
145. Morris J.C. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
146. Robertson D.A., Savva B.M., Coen R.F., Kenny R.A. Cognitive function in the prefrailty and frailty syndrome. J Am Geriatr Soc 2014, 62:2118-2124.
147. Malmstrom T.K., Morley J.E. The frail brain. J Am Med Dir Assoc 2013, 14:453-455.
148. Shimada H., Makizako H., Doi T., et al. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. J Am Med Dir Assoc 2013, 14:518-524.
149. Nishiguchi S., Yamada M., Fukutani N., et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 2015, 16:120-124.
150. Mitnitski A., Fallah N., Rockwood M.R., Rockwood K. Transitions in cognitive status in relation to frailty in older adults: A comparison of three frailty measures. J Nutr Health Aging 2011, 15:863-867.
151. Avila-Funes J.A., Pina-Escudero S.D., Aguilar-Navarro S., et al. Cognitive impairment and low physical activity are the components of frailty more strongly associated with disability. J Nutr Health Aging 2011, 15:683-689.
152. Auyeung T.W., Lee J.S., Kwok T., Woo J. Physical frailty predicts future cognitive decline-a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging 2011, 15:690-694.
153. Parihar R., Mahoney J.R., Verghese J. Relationship of gait and cognition in the elderly. Curr Transl Geriatr Exp Gerontol Rep 2013, 2.
154. Halil M., Cemal Kizilarslanoglu M., Emin Kuyumcu M., et al. Cognitive aspects of frailty: Mechanisms behind the link between frailty and cognitive impairment. J Nutr Health Aging 2015, 19:276-283.
155. McCough E.L., Kelly V.E., Logsdon R.G., et al. Associations between physical performance and executive function in older adults with mild cognitive impairment: Gait speed and the timed "up & go" test. Phys Ther 2011, 91:1198-1207.
156. Ogama N., Sakurai T., Shimizu A., Toba K. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease. J Am Med Dir Assoc 2014, 15:36-41.
157. Bolandzadeh N., Liu-Ambrose T., Aizenstein H., et al. Pathways linking regional hyperintensities in the brain and slower gait. Neuroimage 2014, 99:7-13.
158. Callisaya M.L., Beare R., Phan T., et al. Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people. J Gerontol A Biol Sci Med Sci 2015, 70:358-364.
159. Prins N.D., Scheltens P. White matter hyperintensities, cognitive impairment and dementia: An update. Nat Rev Neurol 2015, 11:157-165.